SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

The product, called Nuvaxovid, is a protein-based vaccine. Health Canada said the vaccine was updated to target the JN.1 variant, an offshoot of Omicron. Nationally, the JN.1 group is currently ...

The European Medical Agency (EMA) had greenlighted the immunizer, which is traded under the brand Nuvaxovid, earlier this week. The drug's developers trust this new medication, developed following ...

With Sanofi (SNY) expected to join the company’s commercialization efforts in 2025, many issues Novavax (NVAX) encountered with the rollout of its COVID-19 shot, Nuvaxovid, in the 2023–24 ...